Drug Database
Back to search

Netherlands· NL-98038db1a6a7

Hyason 150 I.E., poeder voor injectievloeistof

A hyaluronidase product containing hyaluronidase (type niet gespecificeerd), registered in Netherlands by Esteve Pharmaceuticals GmbH. The same ATC class is registered in 7 of our 19 countries.

ATC B06AA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedHyason 150 I.E., poeder voor injectie…ATCB06AA03REGISTER NO.NL-98038db1a6a7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hyaluronidase (type niet gespecificeerd)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hyaluronidase is registered in 7 of 19 countries.

Countries holding a registration under ATC B06AA03 (hyaluronidase), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search hyaluronidase products by name

Hyaluronidase · ATC B06AA03

7 / 19 countries

  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYALURONIDASE (TYPE NIET GESPECIFICEERD)
Manufacturer
Esteve Pharmaceuticals GmbH
Country
Netherlands (NL)
ATC code
B06AA03
ATC class
Hyaluronidase
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    15180

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for hyaluronidase.

Graded by severity as the source publishes them — 84 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hyaluronidase against other medicinesHow interaction checks work

Hyaluronidase · interactions on record

84 records

  • 84 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Hyaluronidase in 5 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All hyaluronidase products

    Authorised across Europe · EMA

    The same active substance is authorised in 5 EEA countries. Names it is sold under:

    • Austria · Hylase Dessau
    • Germany · Hylase Dessau
    • United Kingdom (Northern Ireland) · Hyalase, Hyaluronidase Wockhardt Uk
    • Ireland · Hyaluronidase Pinewood Laboratories
    • Malta · Hyalase

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/a8c8ea2f-d062-4263-b4cb-0f4c3ac15711
GET /v1/drugs/a8c8ea2f-d062-4263-b4cb-0f4c3ac15711?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Poeder voor oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15180_smpc.pdf",
  "strength": null,
  "atc_label": "Hyaluronidase",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15180",
  "excipients": [
    "GELATINE, GEHYDROLYSEERD"
  ],
  "substances": [
    "HYALURONIDASE (TYPE NIET GESPECIFICEERD)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15180.pdf",
  "authorised_at": "1991/11/18",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15180",
  "additional_monitoring": "N"
}
    API referenceMCP serverPlans

    See everything about hyaluronidase.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console